This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Hua Medicine (Shanghai) Ltd.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Fuxing Tang: Innovator in Diabetes Treatment
Introduction
Fuxing Tang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work focuses on the activation of glucokinase, which plays a crucial role in glucose metabolism.
Latest Patents
Fuxing Tang holds a patent for a prodrug of pyrrolidone derivatives as a glucokinase activator. The patent describes a compound of formula (I), or an isotopically labeled product, an enantiomer, a diastereomer, or a pharmaceutically acceptable salt thereof. It also includes a pharmaceutical composition comprising this compound and its use in the treatment of diabetes mellitus and related symptoms. He has 1 patent to his name.
Career Highlights
Throughout his career, Fuxing Tang has worked with Hua Medicine, a company dedicated to advancing diabetes treatment. His role in the company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Fuxing Tang has collaborated with notable colleagues such as Jin She and Li Chen. Their combined expertise has furthered the progress of innovative solutions in diabetes care.
Conclusion
Fuxing Tang's contributions to diabetes treatment through his patent and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical science.